We gratefully acknowledge support from the following funders of the project.
The Wellcome Trust
The Wellcome Trust is the UK's largest charity. It funds innovative biomedical research in the UK and internationally, spending over £600 million each year to support the brightest scientists with the best ideas. It devotes substantial funding to activities outside the British Isles, including funding for researchers in developing and restructuring countries who are working in the area of public health or tropical medicine.
The Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation is dedicated to bringing innovations in health, development, and learning to the global community. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty.
Partnership for Child Development
An international collaboration to improve the health, nutrition and educational development of school-age children in low income countries.
GlaxoSmithKline
GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies. GSK is an active partner in the WHO led effort to eliminate lymphatic filariasis and in late 2010 announced a new five year commitment to expand its albendazole donation programme to treat children at risk of soil-transmitted helminths.
Mectizan Donation Program
The Mectizan Donation Program provides support control and elimination initiatives for onchocerciasis and lymphatic filariasis through the co-administration of Mectizan and albendazole, donated by GlaxoSmithKline. Currently, more than 70 million treatments are approved for onchocerciasis in Africa and Latin America and 80 million for lymphatic filariasis in Africa and Yemen each year.